Stay updated on Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check12 days agoChange DetectedAccess to the study page now shows a 403 Forbidden error page instead of the expected content, with a Home link available. This indicates the page is blocked or access is restricted.SummaryDifference0.5%

- Check19 days agoChange DetectedAn error page (403 Forbidden) replaces the study record content, leaving only a basic header and a Home link. This prevents access to essential study details, locations, and related information.SummaryDifference22%

- Check26 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the study details page.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page version without altering the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the study details page, indicating a minor update to the page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.